All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Podcast: Helmut Katzgraber on Quantum Simulation as the Near-Term Killer App

By

dougfinke

2h ago· 20 min readen

Summary

In this podcast interview, Yuval Boger speaks with Helmut Katzgraber, general partner at 55North (a quantum technologies VC fund) and former quantum leader at AWS. Katzgraber shares his perspective that the most promising near- to mid-term quantum applications lie in quantum simulation for materials science, chemicals, and pharmaceuticals, rather than in optimization problems. He discusses his transition from academia to industry, the quantum investment landscape, and where he sees the most practical value emerging in the quantum computing space.

Source

bskyPodcast: Helmut Katzgraber on Quantum Simulation as the Near-Term Killer Appquantumcomputingreport.com

Key quotes

· 3 pulled
The most promising near- to mid-term quantum applications are in quantum simulation for materials, chemicals, and pharma, rather than optimization.
My name is Helmut Katzgraber. I have had several different roles in the past, and now I'm general partner at 55North, which is a VC fund focused on quantum technologies out of Denmark and to the world.
I think quantum simulation is where we're going to see the most practical value emerging in the quantum computing space.
Snippet from the RSS feed
Yuval Boger interviews Helmut Katzgraber, general partner at 55North and former quantum leader at AWS. They discuss Helmut’s view that the most promising near- to mid-term quantum applications are in quantum simulation for materials, chemicals, and pharma

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.